Publicaciones en las que colabora con Juan Manuel Irache Garreta (29)

2024

  1. Mucus-penetrating and permeation enhancer albumin-based nanoparticles for oral delivery of macromolecules: Application to bevacizumab

    Drug Delivery and Translational Research, Vol. 14, Núm. 5, pp. 1189-1205

  2. Zein nanoparticles extend lifespan in C. elegans and SAMP8 mice

    International Journal of Pharmaceutics, Vol. 666

2023

  1. Gliadin nanoparticles for oral administration of bioactives: Ex vivo and in vivo investigations

    International Journal of Biological Macromolecules, Vol. 249

  2. Zein-based nanospheres and nanocapsules for the encapsulation and oral delivery of quercetin

    International Journal of Pharmaceutics, Vol. 643

2021

  1. 3,5-Dimethyl-4-isoxazoyl selenocyanate as promising agent for the treatment of Leishmania infantum-infected mice

    Acta Tropica, Vol. 215

  2. Caenorhabditis elegans as a model under hyperglicemic conditions to evaluate insulin-loaded nanoparticles

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 202-204

  3. Human serum albumin as a potential nanocarrier for the oral delivery of therapeutic proteins

    RESCIFAR Revista Española de Ciencias Farmacéuticas, Vol. 2, Núm. 2, pp. 15-17

  4. In vivo testing of mucus-permeating nanoparticles for oral insulin delivery using Caenorhabditis elegans as a model under hyperglycemic conditions

    Acta Pharmaceutica Sinica B, Vol. 11, Núm. 4, pp. 989-1002

  5. Oral Efficacy of a Diselenide Compound Loaded in Nanostructured Lipid Carriers in a Murine Model of Visceral Leishmaniasis

    ACS Infectious Diseases, Vol. 7, Núm. 12, pp. 3197-3209

  6. Zein-based nanocarriers for the oral delivery of insulin. In vivo evaluation in Caenorhabditis elegans

    Drug Delivery and Translational Research, Vol. 11, Núm. 2, pp. 647-658

2019

  1. Evaluation of skin permeation and retention of topical dapsone in murine cutaneous leishmaniasis lesions

    Pharmaceutics, Vol. 11, Núm. 11

2018

  1. Coencapsulation of cyclodextrins into poly(anhydride) nanoparticles to improve the oral administration of glibenclamide. A screening on C. elegans

    Colloids and Surfaces B: Biointerfaces, Vol. 163, pp. 64-72

  2. Cyclodextrin-grafted poly(anhydride) nanoparticles for oral glibenclamide administration. In vivo evaluation using C. elegans

    International Journal of Pharmaceutics, Vol. 547, Núm. 1-2, pp. 97-105

  3. Human serum albumin nanoparticles for ocular delivery of bevacizumab

    International Journal of Pharmaceutics, Vol. 541, Núm. 1-2, pp. 214-223

  4. Pegylated nanoparticles for the oral delivery of nimodipine: Pharmacokinetics and effect on the anxiety and cognition in mice

    International Journal of Pharmaceutics, Vol. 543, Núm. 1-2, pp. 245-256

2017

  1. A combination of nanosystems for the delivery of cancer chemoimmunotherapeutic combinations: 1-Methyltryptophan nanocrystals and paclitaxel nanoparticles

    Pharmacological Research, Vol. 126, pp. 77-83

  2. Nanoaggregation of inclusion complexes of glibenclamide with cyclodextrins

    International Journal of Pharmaceutics, Vol. 519, Núm. 1-2, pp. 263-271

  3. Optimization and evaluation of zein nanoparticles to improve the oral delivery of glibenclamide. In vivo study using C. elegans

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 121, pp. 104-112

  4. Supramolecular structure of glibenclamide and β-cyclodextrins complexes

    International Journal of Pharmaceutics, Vol. 530, Núm. 1-2, pp. 377-386

2014

  1. Pharmacokinetics and antitumor efficacy of paclitaxel-cyclodextrin complexes loaded in mucus-penetrating nanoparticles for oral administration

    Nanomedicine, Vol. 9, Núm. 14, pp. 2109-2121